论文部分内容阅读
随着医药科学技术的进步和生产水平的提高,洁霉素生产成本有所下降,加上市场供求的变化,现行价格已显得偏高;而青霉素因主要原料粮食和化工原料价格上涨,影响成本大幅度上升,造成生产企业亏损。为适应市场供求的变化,促进医药生产和经营,满足医疗用药的需要,国家医药管理局、国家物价局决定,对洁霉素、青霉素、盐酸哌替啶等药品价格作有升有降的调整(具体价格详见附表)。并就有关事项做如下规定: 一、洁霉素、青霉素原料出厂价由国家定价改为国家指导价,以调后出厂价为中准价,企业可在
With the advancement of pharmaceutical science and technology and the improvement of the production level, the cost of production of lincomycin has declined, coupled with changes in the supply and demand of the market, the current price has become high; and the price of penicillin has risen due to the increase in the price of main raw materials, food and chemical raw materials, and has affected costs. A substantial increase, resulting in loss of production enterprises. In order to adapt to changes in market supply and demand, promote pharmaceutical production and operations, and meet the needs of medical drugs, the State Administration of Pharmaceuticals and the State Price Bureau have decided to adjust prices of drugs such as lincomycin, penicillin, and pethidine hydrochloride. (Specific prices are detailed in the attached table). The following provisions are made on related issues: 1. The ex-factory price of behenmycin and penicillin raw materials shall be changed from national pricing to national guidance, and the ex-factory price shall be adjusted to the mid-range price. Enterprises can